GERON CORP Operating Lease, Right-of-Use Asset, Amortization Expense
GERON CORP (GERN) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $388.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-05
- GERON CORP operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $196.00K, a 8.29% increase year-over-year.
- GERON CORP operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $192.00K, a 8.47% increase year-over-year.
- GERON CORP operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $188.00K, a 8.05% increase year-over-year.
- GERON CORP operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $184.00K, a 8.24% increase year-over-year.
- GERON CORP operating lease, right-of-use asset, amortization expense for fiscal 2025 was $730.00K, a 8.15% increase from fiscal 2024.
- GERON CORP operating lease, right-of-use asset, amortization expense for fiscal 2024 was $675.00K, a 14.21% increase from fiscal 2023.
- GERON CORP operating lease, right-of-use asset, amortization expense for fiscal 2023 was $591.00K, a 1.90% increase from fiscal 2022.
- GERON CORP operating lease, right-of-use asset, amortization expense for fiscal 2022 was $580.00K, a 2.11% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $388.00K 10-Q · filed 2026-08-05 | $576.00K derived: sum of 3 quarters · filed 2026-08-05 | $760.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $192.00K 10-Q · filed 2026-05-06 | $380.00K derived: sum of 2 quarters · filed 2026-05-06 | $564.00K derived: sum of 3 quarters · filed 2026-05-06 | $745.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $372.00K derived: sum of 2 quarters · filed 2026-03-02 | $553.00K derived: sum of 3 quarters · filed 2026-08-05 | $730.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $365.00K derived: sum of 2 quarters · filed 2026-08-05 | $542.00K 10-Q · filed 2025-11-07 | $716.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $358.00K 10-Q · filed 2026-08-05 | $532.00K derived: sum of 3 quarters · filed 2026-08-05 | $702.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $177.00K 10-Q · filed 2026-05-06 | $351.00K derived: sum of 2 quarters · filed 2026-05-06 | $521.00K derived: sum of 3 quarters · filed 2026-05-06 | $688.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $344.00K derived: sum of 2 quarters · filed 2026-03-02 | $511.00K derived: sum of 3 quarters · filed 2026-03-02 | $675.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $337.00K derived: sum of 2 quarters · filed 2025-11-07 | $501.00K 10-Q · filed 2025-11-07 | $628.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $331.00K 10-Q · filed 2025-08-06 | $458.00K derived: sum of 3 quarters · filed 2026-03-02 | $616.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $164.00K 10-Q · filed 2025-05-07 | $291.00K derived: sum of 2 quarters · filed 2026-03-02 | $449.00K derived: sum of 3 quarters · filed 2026-03-02 | $603.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $285.00K derived: sum of 2 quarters · filed 2026-03-02 | $439.00K derived: sum of 3 quarters · filed 2026-03-02 | $591.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $312.00K derived: sum of 2 quarters · filed 2024-11-07 | $464.00K 10-Q · filed 2024-11-07 | $613.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $306.00K 10-Q · filed 2024-08-08 | $455.00K derived: sum of 3 quarters · filed 2025-02-27 | $601.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $152.00K 10-Q · filed 2024-05-02 | $301.00K derived: sum of 2 quarters · filed 2025-02-27 | $447.00K derived: sum of 3 quarters · filed 2025-02-27 | $591.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $295.00K derived: sum of 2 quarters · filed 2025-02-27 | $439.00K derived: sum of 3 quarters · filed 2025-02-27 | $580.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $290.00K derived: sum of 2 quarters · filed 2023-11-02 | $431.00K 10-Q · filed 2023-11-02 | $596.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $285.00K 10-Q · filed 2023-08-03 | $450.00K derived: sum of 3 quarters · filed 2024-02-28 | $587.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $141.00K 10-Q · filed 2023-05-11 | $306.00K derived: sum of 2 quarters · filed 2024-02-28 | $443.00K derived: sum of 3 quarters · filed 2024-02-28 | $577.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $302.00K derived: sum of 2 quarters · filed 2024-02-28 | $436.00K derived: sum of 3 quarters · filed 2024-02-28 | $568.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $271.00K derived: sum of 2 quarters · filed 2022-11-07 | $403.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $266.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $132.00K 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $777.00K 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |